Targeting protein–protein interactions, a wide open field for drug design

M.M. Bakail, F. Ochsenbein, Comptes Rendus Chimie 19 (2016) 19–27.

Download
OA 2016_ComptesRendueChimie_Bakail.pdf 2.05 MB

Journal Article | Published | English
Author
Bakail, MayIST Austria; Ochsenbein, Francoise
Abstract
Targeting protein–protein interactions has long been considered as a very difficult if impossible task, but over the past decade, front lines have moved. The number of successful examples is exponentially growing. This review presents a rapid overview of recent advances in this field considering the strengths and weaknesses of the small molecule approaches and alternative strategies such as the selection or design of artificial antibodies, peptides or peptidomimetics.

Cibler les interactions protéine–protéine a longtemps été considéré comme une tâche très difficile, voire impossible, mais, depuis les dix dernières années, les lignes ont bougé. Le nombre d’exemples de réussites s’accroît exponentiellement. Cette revue présente un rapide panorama des avancées récentes dans ce domaine, considérant les forces et les faiblesses de l’approche « petite molécule » ainsi que des stratégies alternatives comme la sélection ou le design d’anticorps artificiels, de peptides ou de peptidomimétiques.
Publishing Year
Date Published
2016-02-06
Journal Title
Comptes Rendus Chimie
Volume
19
Issue
1-2
Page
19-27
ISSN
IST-REx-ID

Cite this

Bakail MM, Ochsenbein F. Targeting protein–protein interactions, a wide open field for drug design. Comptes Rendus Chimie. 2016;19(1-2):19-27. doi:10.1016/j.crci.2015.12.004
Bakail, M. M., & Ochsenbein, F. (2016). Targeting protein–protein interactions, a wide open field for drug design. Comptes Rendus Chimie. Elsevier. https://doi.org/10.1016/j.crci.2015.12.004
Bakail, May M, and Francoise Ochsenbein. “Targeting Protein–Protein Interactions, a Wide Open Field for Drug Design.” Comptes Rendus Chimie. Elsevier, 2016. https://doi.org/10.1016/j.crci.2015.12.004.
M. M. Bakail and F. Ochsenbein, “Targeting protein–protein interactions, a wide open field for drug design,” Comptes Rendus Chimie, vol. 19, no. 1–2. Elsevier, pp. 19–27, 2016.
Bakail MM, Ochsenbein F. 2016. Targeting protein–protein interactions, a wide open field for drug design. Comptes Rendus Chimie. 19(1–2), 19–27.
Bakail, May M., and Francoise Ochsenbein. “Targeting Protein–Protein Interactions, a Wide Open Field for Drug Design.” Comptes Rendus Chimie, vol. 19, no. 1–2, Elsevier, 2016, pp. 19–27, doi:10.1016/j.crci.2015.12.004.
All files available under the following license(s):
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0):
Main File(s)
Access Level
OA Open Access
Date Uploaded
2021-01-22
MD5 Checksum
c262814ffdbfe95900256ab9ff42cdf5


Export

Marked Publications

Open Data IST Research Explorer

Search this title in

Google Scholar